| Literature DB >> 35130691 |
Paul Robustelli1,2, Alain Ibanez-de-Opakua3, Cecily Campbell-Bezat1, Fabrizio Giordanetto1, Stefan Becker4, Markus Zweckstetter3,4,5, Albert C Pan1, David E Shaw1,6.
Abstract
Intrinsically disordered proteins (IDPs) are implicated in many human diseases. They have generally not been amenable to conventional structure-based drug design, however, because their intrinsic conformational variability has precluded an atomic-level understanding of their binding to small molecules. Here we present long-time-scale, atomic-level molecular dynamics (MD) simulations of monomeric α-synuclein (an IDP whose aggregation is associated with Parkinson's disease) binding the small-molecule drug fasudil in which the observed protein-ligand interactions were found to be in good agreement with previously reported NMR chemical shift data. In our simulations, fasudil, when bound, favored certain charge-charge and π-stacking interactions near the C terminus of α-synuclein but tended not to form these interactions simultaneously, rather breaking one of these interactions and forming another nearby (a mechanism we term dynamic shuttling). Further simulations with small molecules chosen to modify these interactions yielded binding affinities and key structural features of binding consistent with subsequent NMR experiments, suggesting the potential for MD-based strategies to facilitate the rational design of small molecules that bind with disordered proteins.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35130691 PMCID: PMC8855421 DOI: 10.1021/jacs.1c07591
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419
Figure 1The dynamic binding mechanism of fasudil with α-synuclein observed in MD simulations is consistent with NMR chemical shift perturbation experiments. (A) Contact probabilities between each residue of α-synuclein and fasudil observed in an unbiased 1.5 ms MD simulation run with the a99SB-disp force field. A contact is assigned to all MD frames when the minimum distance between any atom of fasudil and any heavy atom of a protein side-chain residue is <6 Å. Error bars were calculated by blocking (see SI for more details). (B) NMR chemical shift perturbations of α-synuclein measured in the presence of 2.7 mM fasudil. Perturbations in the chemical shift values for 1H and 15N were calculated as [(Δδ1H)2 + (Δδ15N/10)2]1/2. (C) Snapshots of binding modes of fasudil (red carbons) with α-syn-C-term, illustrating the conformational diversity of the bound ensemble. The residues with the highest probability of interacting with fasudil in the bound ensemble are colored blue (Y133, Y136) and green (D135).
Figure 2When in contact with α-synuclein, fasudil dynamically shuttled between different binding modes with different interactions; multiple specific interactions were rare in any given binding mode. (A) The probability of observing interactions between fasudil and α-syn-C-term categorized by type of interaction in the bound ensemble. We note that a given residue can only form certain types of interactions. Error bars were calculated by blocking (see SI for more details). (B) Conditional interaction probability of observing a specific interaction between α-synuclein and fasudil in the bound ensemble, given that a charge–charge interaction had formed between D135 and fasudil. (C) Illustration of the stacking orientation between fasudil’s isoquinoline ring and the Y133 side chain. R is the distance vector between the centers of mass of the six aromatic carbons of Y133 and ten aromatic atoms of the isoquinoline ring on fasudil. The distributions are normalized and shown on a logarithmic scale. (D) Time series of a representative portion of the unbiased MD trajectory of α-synuclein with fasudil showing the formation of different interactions. The presence of a line indicates the formation of a particular interaction. Trajectory frames were sampled every 180 ps.
Figure 4Predicted binding affinities of fasudil analogues with α-synuclein from simulation are in line with subsequently measured chemical shift perturbation titrations from NMR. (A) Structures of fasudil and tested analogues, with ligand 47 having the highest affinity for α-synuclein and ligand 23 the lowest. (B) NMR chemical shift titration curves of the aromatic residues of the C-terminal region of α-synuclein with the five ligands depicted in panel A. (C) Slope of titration curves for each tyrosine residue in α-synuclein, and the average of all tyrosine residues in the C-terminal region of α-synuclein (Y125, Y133, Y136). (D) Titration curves of each compound for Y39, and for the average of all tyrosine residues in the C-terminal region of α-synuclein. Individual titration curves for Y125, Y133, and Y136 are shown in Figure S10. The CSP errors are based on the resolution of the spectra.
Figure 3Predicted interactions of ligand 47 with α-synuclein. (A) Interaction probabilities for each residue 121–140 of α-synuclein and ligand 47 observed in an unbiased MD simulation. (B) The conditional probability of observing interactions between α-synuclein and ligand 47, and between α-synuclein and fasudil, for all conformations containing a charge–charge contact with D135. The values at D135 have been omitted for better visualization of the differences between the two ligands. Error bars were calculated by blocking (see SI for more details). (C) Representative structure of the most populated cluster of conformations of the ligand 47 bound ensemble. In this conformation, ligand 47 (red carbons) can simultaneously stack with Y136, form a hydrogen bond with the backbone amide of Y136, and form charge contacts with D135.